Singapore markets closed

Valerio Therapeutics Société anonyme (C4X.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.1140+0.0140 (+14.00%)
At close: 09:41PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
1,800
1,800
1,443
4,062
1,776
Cost of revenue
533
533
514
368
347
Gross profit
1,267
1,267
929
3,694
1,429
Operating expenses
Research development
9,679
9,679
7,873
3,054
2,107
Selling general and administrative
2,611
2,611
2,635
2,338
2,418
Total operating expenses
20,320
20,320
18,042
9,276
9,243
Operating income or loss
-19,053
-19,053
-17,113
-5,582
-7,814
Interest expense
1,037
138
2,189
848
1,918
Income before tax
-20,325
-20,325
-19,273
-5,836
889
Income tax expense
17
17
285
100
757
Income from continuing operations
-20,342
-20,342
-19,558
-5,936
132
Net income
-20,344
-20,344
-19,562
-5,937
1,089
Net income available to common shareholders
-20,344
-20,344
-19,562
-5,937
1,089
Basic EPS
-0.15
-0.15
-0.18
-0.07
0.01
Diluted EPS
-0.15
-0.15
-0.18
-0.07
0.01
Basic average shares
113,317
135,209
105,746
88,210
72,675
Diluted average shares
154,077
142,075
115,289
91,655
75,373